160 related articles for article (PubMed ID: 2855108)
21. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
[TBL] [Abstract][Full Text] [Related]
22. The cycling pool of cells within human brain tumors: in situ cytokinetics using the monoclonal antibody Ki-67.
Tsanaclis AM; Robert F; Michaud J; Brem S
Can J Neurol Sci; 1991 Feb; 18(1):12-7. PubMed ID: 1645210
[TBL] [Abstract][Full Text] [Related]
23. The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time.
Schröder R; Bien K; Kott R; Meyers I; Vössing R
Acta Neuropathol; 1991; 82(5):389-94. PubMed ID: 1767633
[TBL] [Abstract][Full Text] [Related]
24. p53 protein expression in central nervous system tumors: an immunohistochemical study with CM1 polyvalent and DO-7 monoclonal antibodies.
Karamitopoulou E; Perentes E; Diamantis I
Acta Neuropathol; 1993; 85(6):611-6. PubMed ID: 8337939
[TBL] [Abstract][Full Text] [Related]
25. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
[TBL] [Abstract][Full Text] [Related]
26. Progression of astrocytomas and meningiomas: an evaluation in vitro.
Maes L; Kalala JP; Cornelissen M; de Ridder L
Cell Prolif; 2007 Feb; 40(1):14-23. PubMed ID: 17227292
[TBL] [Abstract][Full Text] [Related]
27. [Factors affecting the prognosis of brain tumors].
Yoshimine T; Hayakawa T; Mogami H
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2022-7. PubMed ID: 2840033
[TBL] [Abstract][Full Text] [Related]
28. Expression of non-glial intermediate filament proteins in gliomas.
Hirato J; Nakazato Y; Ogawa A
Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
[TBL] [Abstract][Full Text] [Related]
29. Brain tumor invasion rate measured in vitro does not correlate with Ki-67 expression.
Khoshyomn S; Lew S; DeMattia J; Singer EB; Penar PL
J Neurooncol; 1999; 45(2):111-6. PubMed ID: 10778726
[TBL] [Abstract][Full Text] [Related]
30. Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
Sasaki A; Naganuma H; Kimura R; Isoe S; Nakano S; Nukui H; Suzuki K; Kawaoi A
Acta Neurochir (Wien); 1992; 117(3-4):178-81. PubMed ID: 1357920
[TBL] [Abstract][Full Text] [Related]
31. Image analysis of proliferating cells in tumors of the human nervous system: an immunohistological study with the monoclonal antibody Ki-67.
Hopf NJ; Bremm J; Bohl J; Perneczky A
Neurosurgery; 1994 Nov; 35(5):917-23; discussion 923. PubMed ID: 7838342
[TBL] [Abstract][Full Text] [Related]
32. [Cellular kinetics of cerebral glioma: study of the proliferative activity using monoclonal antibody Ki 67. Apropos of 60 cases].
Parent M; Blond S; Gosset P; Lejeune JP; Lesoin F; Dhellemmes P; Jomin M; Christiaens JL; Dupont A
Arch Anat Cytol Pathol; 1990; 38(3):81-5. PubMed ID: 2363592
[TBL] [Abstract][Full Text] [Related]
33. [Quantitative histological observations in gliomas (author's transl)].
Martin H; Schmidt D; Heim I; Scholze K; Tanner G
Zentralbl Allg Pathol; 1980; 124(1-2):31-9. PubMed ID: 6251667
[TBL] [Abstract][Full Text] [Related]
34. Apoptosis and cell proliferation in human neuroepithelial tumors.
Schiffer D; Cavalla P; Migheli A; Chiò A; Giordana MT; Marino S; Attanasio A
Neurosci Lett; 1995 Aug; 195(2):81-4. PubMed ID: 7478273
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
36. Proliferating cell nuclear antigen (PCNA) and Ki-67 immunopositivity in human astrocytic tumours.
Kordek R; Biernat W; Alwasiak J; Liberski PP
Acta Neurochir (Wien); 1996; 138(5):509-12; discussion 513. PubMed ID: 8800324
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue.
Hunter SB; Varma V; Shehata B; Nolen JD; Cohen C; Olson JJ; Ou CY
J Histochem Cytochem; 2005 Aug; 53(8):963-9. PubMed ID: 16055749
[TBL] [Abstract][Full Text] [Related]
38. Cell proliferation in serial biopsies through human malignant brain tumours: measurement using Ki67 antibody labelling.
Parkins CS; Darling JL; Gill SS; Revesz T; Thomas DG
Br J Neurosurg; 1991; 5(3):289-98. PubMed ID: 1892572
[TBL] [Abstract][Full Text] [Related]
39. Neuropathology of malignant gliomas.
Bruner JM
Semin Oncol; 1994 Apr; 21(2):126-38. PubMed ID: 8153659
[TBL] [Abstract][Full Text] [Related]
40. Paraffin section p53 protein immunohistochemistry in neuroectodermal tumors.
Ng HK; Lo SY; Huang DP; Poon WS
Pathology; 1994 Jan; 26(1):1-5. PubMed ID: 8165016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
